A final-stage clinical trial comparing a new long-acting, once-weekly pill to treat schizophrenia symptoms with the existing daily treatment has found that both produce comparable therapeutic effects.

New guidelines have been developed for the treatment of schizophrenia after a collaboration of international experts from 30 countries. Skip to content. Menu. Medical Home Life Sciences Home.

Older adults with schizophrenia are not a homogenous patient population with various sub-groups that differ significantly in terms of comorbid illness, mortality rates and causes.